Goodwin advised Codiak BioSciences on the deal Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the closing of a Series C financing round of…
Codiak BioSciences’ $76.5 Million Series C Financing
Goodwin advised Codiak BioSciences on the deal Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the closing of a Series C financing round of…